Treatment of multiple myeloma with M-2 protocol and without maintenance therapy
- 1 October 1983
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 19 (10), 1345-1351
- https://doi.org/10.1016/0277-5379(93)90002-m
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Treatment of multiple myelomaCancer Treatment Reviews, 1981
- Vindesine therapy in melphalan-resistant multiple myelomaEuropean Journal of Cancer (1965), 1981
- Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocolAmerican Journal Of Medicine, 1977
- Multiple myeloma: quantitative staging and assessment of response with a programmable pocket calculatorBlood, 1977
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- Expansion of the growth fraction in multiple myeloma with alkylating agentsBlood, 1975
- Combination chemotherapy of multiple myeloma with Alkeran, Cytoxan, vincristine, prednisone, and BCNUCancer, 1974
- Melphalan and prednisone: An effective combination for the treatment of multiple myelomaAmerican Journal Of Medicine, 1973
- Myelomatosis: Comparison of Melphalan and Cyclophosphamide TherapyBMJ, 1971
- Treatment for Multiple MyelomaJAMA, 1969